(Q34705570)

4 August 2017

title

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials (English)

1 reference

4 August 2017

1 reference

3

Cynthia A Toth

1 reference

4 August 2017

Glenn J Jaffe

1

1 reference

4 August 2017

Daniel F Martin

2

1 reference

4 August 2017

Ebenezer Daniel

4

1 reference

4 August 2017

Maureen G Maguire

5

1 reference

4 August 2017

Gui-Shuang Ying

6

1 reference

4 August 2017

Juan E Grunwald

7

1 reference

4 August 2017

Jiayan Huang

8

1 reference

4 August 2017

Comparison of Age-related Macular Degeneration Treatments Trials Research Group

9

1 reference

4 August 2017

publication date

1 May 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

120

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1860-1870

1 reference

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Ranibizumab for neovascular age-related macular degeneration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737287

Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23642377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.OPHTHA.2013.01.073

1 reference

4 August 2017

1 reference

4 August 2017

1 reference